Beranda › Karsinoma Urotelial (Sel Transisional) › California › Orange
Uji klinis Karsinoma Urotelial (Sel Transisional) di Orange, CA
10 studi untuk Karsinoma Urotelial (Sel Transisional) mencari peserta di lokasi sekitar Orange (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Menerima pesertaFase 3
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
Menerima pesertaFase 1/2
- University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 1045), Orange
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Menerima pesertaFase 1/2
- UC Irvine Health, Orange
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Menerima pesertaFase 3
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Menerima pesertaFase 1
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Menerima pesertaFase 3
- UC Irvine Health. Chao Family Comprehensive Cancer Center, Orange
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Menerima pesertaFase awal 1
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Menerima pesertaFase 2
- UC Irvine Health, Orange
Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence
Menerima pesertaFase 2
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Orange
Uji klinis Karsinoma Urotelial (Sel Transisional) di kota lain
- Nashville, TN23 studi
- New York City, NY22 studi
- Houston, TX19 studi
- Dallas, TX18 studi
- Edison, NJ18 studi
- Los Angeles, CA17 studi
- Queens, NY15 studi
- Chicago, IL14 studi
- Arlington, VA12 studi
- Boston, MA11 studi
- San Antonio, TX11 studi
- Austin, TX10 studi
Studi lain di Orange
- Kanker Paru Non-Sel Kecil25 studi
- Kanker Metastatik20 studi
- Kanker Kolorektal16 studi
- Kanker Ovarium16 studi
- Kanker Pankreas15 studi
- Melanoma14 studi
- Kanker Hati (Karsinoma Hepatoseluler)14 studi
- Kanker Payudara14 studi
- Kanker Paru14 studi
- Kanker Prostat14 studi
- Kanker Lambung13 studi
- Kanker (semua jenis)13 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.